​

GLP-1 drugs is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include china updates national essential medicines list for first time in eight years, adding semaglutide and 115 other drugs as domestic oral glp-1 treatments show progress, online glp-1 prescription services found to lack clinical oversight in secret shopper study, glp-1 drugs taken around pregnancy show no increased risk of birth defects in new study, among other significant events and policy changes.

Source: Geo Health Space